The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis.

Y-G Zhang,X-B Li,J Zhang,J Huang,C He,C Tian,Y Deng,H Wan,D Shrestha,Y-Y Yang,H Fan

DOI: https://doi.org/10.1111/j.1398-9995.2010.02438.x

IF: 12.4

2011-01-01

Allergy

Abstract:P>Background: The insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme (ACE) gene has been implicated in susceptibility to asthma, but a large number of studies have reported inconclusive results. The aim of this study is to investigate the association between the I/D polymorphism of ACE gene and asthma risk by meta-analysis. Methods: We searched Medline (Ovid), Pubmed, CNKI, Wanfang, and Weipu database, covering all papers until March 12, 2010. Statistical analysis was performed by using the software revman 4.2 (The Cochrane Collaboration, http://www.cochrane.org) and stata 10.0 (StataCorp, College Station, TX, USA, http://www.stata.com). Results: A total of 1946 cases and 2152 controls in 18 case-control studies were included in this meta-analysis. The results indicated that the DD homozygote carriers had a 59% increased risk of asthma, when compared with the homozygotes II and heterozygote DI [odds ratio (OR) = 1.59, 95% confidence interval (CI): 1.16-2.18]. In the subgroup analysis by ethnicity, significant elevated risks were associated with DD homozygote carriers in Asians (OR = 2.02 and 95% CI: 1.29-3.16 for DD vs DI+II) but not in Caucasians (OR = 1.14 and 95% CI: 0.76-1.72 for DD vs DI+II). In the subgroup analysis by age, significant elevated risks were associated with DD homozygote carriers in children (OR = 2.44 and 95% CI: 1.36-4.38 for DD vs II+DI) but not in adults (OR = 1.54 and 95% CI: 0.94-2.51 for DD vs II+DI). Conclusions: This meta-analysis suggested that the I/D polymorphism of ACE gene would be a risk factor of asthma. To further evaluate gene-to-gene and gene-to-environment interactions between polymorphisms of ACE gene and asthma risk, more studies with large groups of patients are required.